IL6 and breast cancer: In this study, the IL-6-knockdown in the 4T1 murine mammary carcinoma cell line (4T1IL-6low) was successfully established to investigate the effects of tumor-derived IL-6 on the growth and invasion of breast cancer cells by infecting lentiviral shIL-6 into mammary carcinoma 4T1 cells.